MORGAN STANLEY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.2 BRL | +0.13% |
|
-1.42% | +11.34% |
| May. 31 | Marvell Technology's Optical, Custom Silicon for AI to Drive Growth, Morgan Stanley Says | MT |
| May. 31 | Saudi Arabia sets new test for international interest with $13.1 bln Aramco sale | RE |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- Based on current prices, the company has particularly high valuation levels.
- The company is highly valued given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Investment Banking & Brokerage Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +11.34% | 159B | - | ||
| +18.34% | 155B | C+ | ||
| +6.51% | 134B | B- | ||
| +21.13% | 119B | C+ | ||
| -8.59% | 35.44B | B+ | ||
| +10.10% | 25.44B | B | ||
| +25.74% | 21.38B | B+ | ||
| -9.42% | 19.99B | B+ | ||
| +49.05% | 18.02B | B | ||
| +4.03% | 15.6B | C- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- MS Stock
- MSBR34 Stock
- Ratings Morgan Stanley
